background
banner

FUARTE 500 mg Price

Active Substance: Deferasirox .

1455
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on FUARTE 500 mg Dispersible tablet page.
This medicine contains an important and useful components, as it consists of Deferasirox .
FUARTE 500 mg is available in the market in concentration 500 mg/tablet and in the form of Dispersible tablet.

ABDI IBRAHIM ILAC SAN.VE Tic. A.S. is the producer of FUARTE 500 mg and it is imported from TURKEY, The most popular alternatives of FUARTE 500 mg are listed downward .

Mode Of Action

Deferasirox is an orally active chelator that is selective for iron (as Fe3+ ion). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. It is used in the management of chronic iron overload.

Indication

  • Chronic iron overload.

Precaution

Monitor renal function and CBC before starting treatment and regularly during treatment; may need to reduce dose or stop treatment if serum creatinine levels are persistently elevated. May increase LFTs. Perform audiological and ophthamological tests before starting treatment and yrly thereafter. Pregnancy. Lactation: not known whether excreted in breast milk, use caution

Side Effects

  • >10% Serum creatinine increase (dose related; 7-38%)
  • Abdominal pain (21-28%)
  • Nausea (11-23%)
  • Vomiting (10-21%)
  • Diarrhea (12-20%)
  • Proteinuria (19%)
  • Pyrexia (19%)
  • Headache (16%)
  • Cough (14%)
  • Nasopharyngitis (13%)
  • Pharyngolaryngeal pain (11%)
  • Influenza (11%)
  • Rash (8-11%) 1-10% Respiratory tract infection (10%)
  • Bronchitis (9%)
  • ALT increased (2-8%)
  • Arthralgia
  • back pain (6-7%)
  • Acute tonsillitis (6%)
  • Rhinitis (6%)
  • Fatigue (6%)
  • Ear infection (5%)
  • Transaminitis (4%)
  • Urticaria (4%) <1% Anaphylaxis
  • Angioedema
  • Cytopenias
  • including agranulocytosis
  • neutropenia and thrombocytopenia; leukocytoclastic vasculitis Potentially Fatal: Acute renal failure
  • serious hypersensitivity reactions such as angioedema and anaphylaxis.

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Not to be used with aluminium-containing antacids as it may chelate aluminium.

Alternatives Price List

  • MAGNETO 500mgUAD 2041
  • FUARTE 500 mg UAD 1455
  • FUARTE 250 mg UAD 733
  • FUARTE 125 mg UAD 380

Releated Products

banner

Report Price Error

Please feel welcome to contact Us with any price or medical error. Our doctors will receive any reports.